HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy-Reference-Cited by-同舟云学术

HIV-1–specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapy

Published:1999-09-15 Issue:6 Volume:104 Page:R13-R18
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Ortiz Gabriel M.,Nixon Douglas F.,Trkola Alexandra,Binley James,Jin Xia,Bonhoeffer Sebastian,Kuebler Peter J.,Donahoe Sean M.,Demoitie Marie-Ange,Kakimoto William M.,Ketas Tom,Clas Brian,Heymann Jonas J.,Zhang Linqi,Cao Yunzhen,Hurley Arlene,Moore John P.,Ho David D.,Markowitz Martin

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference32 articles.

1. Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

2. Serum HIV-1 RNA Levels and Time to Development of AIDS in the Multicenter Hemophilia Cohort Study

3. Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy

4. Recovery of Replication-Competent HIV Despite Prolonged Suppression of Plasma Viremia

5. Identification of a Reservoir for HIV-1 in Patients on Highly Active Antiretroviral Therapy

Cited by 212 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. An XGBoost-Based Fitted Q Iteration for Finding the Optimal STI Strategies for HIV Patients;IEEE Transactions on Neural Networks and Learning Systems;2022

2. Brief Report: Toll-like Receptor 9-1635A/G Polymorphism Is Associated With HIV-1 Rebound After Four Weeks of Interruption of Antiretroviral Therapy;JAIDS Journal of Acquired Immune Deficiency Syndromes;2020-10-01

3. An analysis of functional curability on HIV infection models with Michaelis-Menten-type immune response and its generalization;Discrete & Continuous Dynamical Systems - B;2017

4. Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial;PLOS ONE;2016-05-18

5. No evidence of posttreatment control after early initiation of antiretroviral therapy;AIDS;2015-10-23